NCT06476704View on ClinicalTrials.gov

Study of Preoperative RAdiation Therapy With Concomitant Liposomal Transcrocetin (L-TC) in Soft tISsue Sarcomas

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

October 15, 2027

Study Completion Date

June 1, 2032

Conditions
Sarcoma
Interventions
DRUG

Administration of L-TC

Administration of L-TC (300 mg) as an IV perfusion, daily before each radiotion session

RADIATION

HFRT alone

"HFRT : 30 Gy in 5 fractions of 6 Gy.~1 fraction per day, 5 days per week."

Trial Locations (2)

Unknown

CGFL, Dijon

ICANS, Strasbourg

All Listed Sponsors
collaborator

LEAF4Life, Inc.

INDUSTRY

lead

Institut de cancérologie Strasbourg Europe

OTHER